Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $467,911 - $769,535
3,963 New
3,963 $469,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $205,947 - $336,081
-912 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $202,372 - $441,836
912 New
912 $351,000
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $209,710 - $541,853
-3,190 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $173,344 - $302,571
3,190 New
3,190 $226,000
Q4 2019

Feb 14, 2020

SELL
$13.93 - $21.28 $41,790 - $63,840
-3,000 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$12.26 - $18.07 $36,780 - $54,210
3,000 New
3,000 $48,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.